Neuroone Medical Technologies (NMTC) Property, Plant & Equipment (Net) Growth (3y) (2022 - 2026)
Neuroone Medical Technologies (NMTC) Property, Plant & Equipment (Net) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 7.96% |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | -29.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.88% |
| Mar 31, 2026 | -23.88% |
| Dec 31, 2025 | -9.90% |
| Sep 30, 2025 | -9.83% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | 5.28% |
| Dec 31, 2024 | 20.79% |
| Sep 30, 2024 | 23.12% |
| Jun 30, 2024 | 44.58% |
| Mar 31, 2024 | 45.48% |
| Dec 31, 2023 | 48.95% |
| Sep 30, 2023 | 46.85% |
| Jun 30, 2023 | 79.79% |
| Mar 31, 2023 | 83.26% |
| Dec 31, 2022 | 69.91% |
| Sep 30, 2022 | 89.42% |
| Jun 30, 2022 | 80.90% |